| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.025 | 5.645 | 5.254 | 1.719 | 0 | 8.238 | 14.550 | 14.478 | 13.595 | 13.869 |
| Total Income - EUR | 2.025 | 5.645 | 5.254 | 1.719 | 0 | 8.238 | 14.550 | 14.478 | 13.595 | 13.869 |
| Total Expenses - EUR | 377 | 2.003 | 1.523 | 567 | 47 | 1.739 | 3.713 | 5.516 | 5.688 | 6.194 |
| Gross Profit/Loss - EUR | 1.647 | 3.642 | 3.732 | 1.153 | -47 | 6.499 | 10.837 | 8.962 | 7.908 | 7.675 |
| Net Profit/Loss - EUR | 1.587 | 3.473 | 3.574 | 1.101 | -47 | 6.460 | 10.401 | 8.528 | 6.479 | 6.279 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neurosar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 108 | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 2.773 | 2.149 |
| Current Assets | 1.564 | 3.526 | 3.669 | 1.161 | 40 | 6.497 | 11.284 | 13.359 | 13.395 | 15.733 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 445 | 438 | 0 | 0 | 70 | 0 | 0 | 0 | 0 |
| Cash | 1.564 | 3.081 | 3.231 | 1.161 | 40 | 6.427 | 11.284 | 13.359 | 13.395 | 15.733 |
| Shareholders Funds | 1.632 | 3.529 | 3.629 | 1.161 | 38 | 6.497 | 11.195 | 13.268 | 15.866 | 17.780 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40 | 40 | 39 | 0 | 3 | 0 | 89 | 91 | 302 | 103 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurosar S.r.l.